ABCB11 and metabolic dysfunction-associated steatotic liver disease: Since hepatobiliary transporters critically determine hepatic BA flux and concentrations, it is attractive to hypothesize that alterations of BSEP – the rate limiting step for BA efflux – could contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).